{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T15:53:07Z","timestamp":1753890787637,"version":"3.41.2"},"reference-count":29,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:00:00Z","timestamp":1746748800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170860"],"award-info":[{"award-number":["82170860"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Familial hypocalciuric hypercalcemia (FHH) is an autosomal dominant disorder and represents a rare cause of hypercalcemia. It stems from variants in the calcium-sensing receptor gene (CaSR), G-protein subunit alpha11 gene (GNA11), or adaptor-related protein complex 2 gene (AP2S1), among which variants in the CaSR gene are the most prevalent. However, challenges in the current diagnosis of FHH persist, owing to the overlap in clinical features with primary hyperparathyroidism (PHPT).<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>The three reported patients demonstrated similar clinical presentations such as hypercalcemia and relative hypocalciuria. In two of them, the parathyroid hormone (PTH) level was elevated, while in one, it was normal. Initially, all of them received conventional hypocalcemic treatment. After comprehensive medical history collection and auxiliary examination were conducted to exclude other causes of hypercalcemia, whole exome sequencing (WES) and sanger sequencing were carried out. The results showed that the three patients carried different variants sites in the CaSR gene, namely, c.887G&amp;gt;A, c.2027 &amp;gt; G, c.1608 + 3A&amp;gt;T and c.332C&amp;gt;T. In addition, c.887G&amp;gt;A was also found in the son and grandson of patient 1. The analysis of the conservation of homologous species and the prediction of protein structure for all variant sites demonstrated that due to the heterozygous variants in CaSR, relatively conserved amino acids were altered, affecting the interaction forces between adjacent amino acids, resulting in changes in the protein structure, which might affect the function of the protein.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In conclusion, we report three cases of FHH1 with different heterozygous variant sites in the CaSR gene. This study has expanded the spectrum of variants. It is of great significance for the genetic screening, diagnosis, counseling, and research of hypercalcemia-related genes and become a key resource for enhancing clinicians\u2019 understanding of FHH1.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fgene.2025.1570141","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T04:10:56Z","timestamp":1746763856000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case report: Clinical and genetic characteristics of heterozygous CaSR variants in three Chinese females with familial hypocalciuric hypercalcemia type 1: a report of three cases"],"prefix":"10.3389","volume":"16","author":[{"given":"Ruxuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiping","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dandan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinli","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,5,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1007\/s00467-010-1547-5","article-title":"Beneficial effect of cinacalcet in a child with familial hypocalciuric hypercalcemia","volume":"25","author":"Alon","year":"2010","journal-title":"Pediatr. Nephrol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"101097","DOI":"10.1016\/j.bonr.2021.101097","article-title":"Prenatal features and neonatal management of severe hyperparathyroidism caused by the heterozygous inactivating calcium-sensing receptor variant, Arg185Gln: a case report and review of the literature","volume":"15","author":"Aubert-Mucca","year":"2021","journal-title":"Bone. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.aace.2022.05.002","article-title":"A novel missense CASR gene sequence variation resulting in familial hypocalciuric hypercalcemia","volume":"8","author":"Bletsis","year":"2022","journal-title":"AACE Clin. Case Rep."},{"key":"B4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1530\/EJE-09-0257","article-title":"Association of parathyroid adenoma and familial hypocalciuric hypercalcaemia in a teenager","volume":"161","author":"Brachet","year":"2009","journal-title":"Eur. J. Endocrinol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1111\/j.1365-2265.2008.03259.x","article-title":"Discriminative power of three indices of renal calcium excretion for the distinction between familial hypocalciuric hypercalcaemia and primary hyperparathyroidism: a follow-up study on methods","volume":"69","author":"Christensen","year":"2008","journal-title":"Clin. Endocrinol. (Oxf)."},{"key":"B6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1097\/MED.0b013e32834c3c7c","article-title":"Familial hypocalciuric hypercalcaemia: a review","volume":"18","author":"Christensen","year":"2011","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"B7","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1677\/JME-08-0164","article-title":"Calcium-sensing receptor mutations and denaturing high performance liquid chromatography","volume":"42","author":"Cole","year":"2009","journal-title":"J. Mol. Endocrinol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.cca.2014.05.026","article-title":"Evaluation of damaging effects of splicing mutations: validation of an in vitro method for diagnostic laboratories","volume":"436","author":"Di Resta","year":"2014","journal-title":"Clin. Chim. Acta."},{"key":"B9","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1210\/jc.2014-1414","article-title":"Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the fourth international workshop","volume":"99","author":"Eastell","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3969\/j.issn.1674-2591.2024.01.007","article-title":"A case of hypercalcemia caused by CaSR gene mutation","volume":"1","author":"Gao","year":"2024","journal-title":"Chin. J. Osteoporos. Bone Mineral Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JME-19-0104","article-title":"Molecular and clinical insights from studies of calcium-sensing receptor mutations","volume":"63","author":"Gorvin","year":"2019","journal-title":"J. Mol. Endocrinol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11154-019-09529-5","article-title":"A clinical perspective of parathyroid hormone related hypercalcaemia","volume":"21","author":"Han","year":"2020","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.1093\/hmg\/dds105","article-title":"Identification of 70 calcium-sensing receptor mutations in hyper- and hypo-calcaemic patients: evidence for clustering of extracellular domain mutations at calcium-binding sites","volume":"21","author":"Hannan","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"B14","first-page":"193","article-title":"Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity","volume":"53","author":"Heath","year":"1993","journal-title":"Am. J. Hum. Genet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"853","DOI":"10.24953\/turkjped.2022.1040","article-title":"Cinacalcet therapy in a child with novel homozygous CASR p.glu353lys mutation causing familial hypocalciuric hypercalcemia type 1: case report and review of the literature","volume":"65","author":"Koca","year":"2023","journal-title":"Turk. J. Pediatr."},{"key":"B16","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.beem.2018.05.004","article-title":"Familial hypocalciuric hypercalcemia and related disorders","volume":"32","author":"Lee","year":"2018","journal-title":"Best. Pract. Res. Clin. Endoc. Metab."},{"key":"B17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00198-019-05170-9","article-title":"Parathyroid hormone-dependent familial hypercalcemia with low measured PTH levels and a presumptive novel pathogenic mutation in CaSR","volume":"31","author":"Mahajan","year":"2020","journal-title":"Osteoporos. Int."},{"key":"B18","doi-asserted-by":"publisher","first-page":"L29","DOI":"10.1210\/jc.2014-4221","article-title":"Letter to the editor: distinguishing typical primary hyperparathyroidism from familial hypocalciuric hypercalcemia by using an index of urinary calcium","volume":"100","author":"Marx","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2017-01606","article-title":"Calcimimetic use in familial hypocalciuric hypercalcemia-a perspective in endocrinology","volume":"102","author":"Marx","year":"2017","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"B20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1472-6823-14-81","article-title":"A novel mutation in calcium-sensing receptor gene associated to hypercalcemia and hypercalciuria","volume":"14","author":"Mastromatteo","year":"2014","journal-title":"BMC Endocr. Disord."},{"key":"B21","unstructured":"Familial hypocalciuric hypercalcemia\n          \n          \n            \n              Nava Suarez\n              C. C.\n            \n            \n              Anastasopoulou\n              C.\n            \n            \n              Kathuria\n              P.\n            \n          \n          \n          2024"},{"key":"B22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1053\/j.ajkd.2020.02.439","article-title":"Comparative effectiveness of calcimimetic agents for secondary hyperparathyroidism in adults: a systematic review and network meta-analysis","volume":"76","author":"Palmer","year":"2020","journal-title":"Am. J. Kidney Dis."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1016\/j.ajhg.2022.10.013","article-title":"Calibration of computational tools for missense variant pathogenicity classification and ClinGen recommendations for PP3\/BP4 criteria","volume":"109","author":"Pejaver","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"B24","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00467-004-1671-1","article-title":"Calcimimetics--fooling the calcium receptor","volume":"20","author":"Ritz","year":"2005","journal-title":"Pediatr. Nephrol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"e935821","DOI":"10.12659\/MSM.935821","article-title":"A review of current clinical concepts in the pathophysiology, etiology, diagnosis, and management of hypercalcemia","volume":"28","author":"Tonon","year":"2022","journal-title":"Med. Sci. Monit."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e21940","DOI":"10.1097\/MD.0000000000021940","article-title":"Familial hypocalciuric hypercalcemia caused by homozygous CaSR gene mutation: a case report of a family","volume":"99","author":"Wang","year":"2020","journal-title":"Med. Baltim."},{"key":"B27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10157-020-01936-2","article-title":"Safety and efficacy of etelcalcetide, an intravenous calcimimetic, for up to 52 weeks in hemodialysis patients with secondary hyperparathyroidism: results of a post-marketing surveillance in Japan","volume":"25","author":"Yokoyama","year":"2021","journal-title":"Clin. Exp. Nephrol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3109\/0886022X.2013.832319","article-title":"Review of cinacalcet hydrochloride in the management of secondary hyperparathyroidism","volume":"36","author":"Yousaf","year":"2014","journal-title":"Ren. Fail."},{"key":"B29","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12902-021-00881-9","article-title":"Persistent hypercalcemia with similar familial hypocalciuric hypercalcemia features: a case report and literature review","volume":"21","author":"Zahedi","year":"2021","journal-title":"BMC Endocr. Disord."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1570141\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T04:11:00Z","timestamp":1746763860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2025.1570141\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,9]]},"references-count":29,"alternative-id":["10.3389\/fgene.2025.1570141"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2025.1570141","relation":{},"ISSN":["1664-8021"],"issn-type":[{"type":"electronic","value":"1664-8021"}],"subject":[],"published":{"date-parts":[[2025,5,9]]},"article-number":"1570141"}}